tiprankstipranks
Atossa Therapeutics (DE:YAG2)
FRANKFURT:YAG2

Atossa Therapeutics (YAG2) Ownership - Who Owns Atossa Therapeutics?

1 Followers

Atossa Therapeutics (YAG2) Ownership Overview

0.00%0.00%0.02%99.98%
0.02% Other Institutional Investors
99.98% Public Companies and
Individual Investors
The ownership structure of Atossa Therapeutics (DE:YAG2) stock is a mix of institutional, retail and individual investors. Approximately 0.02% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 99.98% is owned by Public Companies and Individual Investors.
The ownership structure of Atossa Therapeutics (DE:YAG2) stock is a mix of institutional, retail and individual investors. Approximately 0.02% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 99.98% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Apr 11, 2024Bought$44250
Nov 17, 2023
Gregory Weaver
Former Evp, Cfo, & Director
Sold$32500
Jun 20, 2023
Gregory Weaver
Former Evp, Cfo, & Director
Bought$48500

Recent Hedge Fund Trading Activity

Currently, No Data Available
Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
55Insider69
9,400Insider11,712
4,796,858Insider5,976,885
10,000Insider12,460
17,674Insider22,022
100Insider125
5,528,055Institution7,313,617
13,512Institution17,876
28,009Institution37,056
1,088,688Institution1,440,334

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
28,009Institution37,056
1,088,688Institution1,440,334
338,308Institution447,581
5,443,721Institution7,202,043
87,558Institution115,839
98,096Institution129,781
45,962Institution60,808
-2,680Institution-3,546

Top ETF Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Atossa Therapeutics (DE:YAG2)?
According to the latest TipRanks data, approximately 0.02% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 99.98% is held by retail investors.
    What percentage of Atossa Therapeutics (DE:YAG2) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.02% of Atossa Therapeutics (DE:YAG2) stock is held by institutional investors.
      What percentage of Atossa Therapeutics (DE:YAG2) stock is held by retail investors?
      According to the latest TipRanks data, approximately 99.98% of Atossa Therapeutics (DE:YAG2) stock is held by retail investors.
        Who owns the most shares of Atossa Therapeutics (DE:YAG2)?
        Gregory Weaver owns the most shares of Atossa Therapeutics (DE:YAG2).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis